Textbook of Personalized Medicine - Second Edition [2015]

197

References

Dhiman N, Ovsyannikova IG, Vierkant RA, et al. Associations between SNPs in toll-like receptors
and related intracellular signaling molecules and immune responses to measles vaccine: pre-
liminary results. Vaccine. 2008;26:1731–6.
Jain KK. Personalized cancer vaccines. Expert Opin Biol Ther. 2010;12:1637–47.
Jain KK. Role of biological therapies in the development of personalized medicine. Expert Opin
Biol Ther. 2012;12:1–5.
Jain KK. Cell therapy: technologies, markets and companies. Basel: Jain PharmaBiotech; 2015a.
Jain KK. Gene therapy: technologies, markets and companies. Basel: Jain PharmaBiotech; 2015b.
Jain KK. RNAi: technologies, markets and companies. Basel: Jain PharmaBiotech; 2015c.
Kim C. Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and
safe application. Blood Res. 2014;49:7–14.
Mavroudi M, Zarogoulidis P, Porpodis K, et al. Stem cells’ guided gene therapy of cancer: new
frontier in personalized and targeted therapy. J Cancer Res Ther (Manch). 2014;2:22–33.
Mook OR, Baas F, de Wissel MB, Fluiter K. Allele-specifi c cancer cell killing in vitro and in vivo
targeting a single-nucleotide polymorphism in POLR2A. Cancer Gene Ther. 2009;16:532–8.

References